NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY:
|
|
- Erin Bishop
- 6 years ago
- Views:
Transcription
1 NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY: Potent biological scaffolds strategically control stem cell fate and function, allowing our allografts to harness the regenerative potential of patient s own stem cells and improve surgical outcomes Lattice Biologics Inc. All Rights Reserved.
2 TISSUE ENGINEERING & REGENERATIVE MEDICINE Tissue Structure: The majority of living tissue s volume is comprised of extracellular space between groups of tightly packed cells. This void is filled with a complex meshwork called the Extracellular Matrix. Extracellular Matrix (ECM): A dynamic, physiologically active structure of molecules secreted by cells that provides structural and biochemical support to surrounding cells and is a component of all living tissues. Provides structural support for cells within tissue. Guides cells division, growth, and development. Determines how tissues look and function. Stem Cells - Powerful Agents of Healing: Tissue repair requires the recruitment of properly functioning stem cells to the wound location. They release growth factor proteins that speed up and enhance healing. Ability to regenerate and differentiate into different types of cells (pluripotency) offers incredible therapeutic potential for tissue engineering. Both ECM and Stem Cells are essential for growth and wound healing processes Lattice Biologics Inc. All Rights Reserved.
3 TISSUE ENGINEERING & REGENERATIVE MEDICINE Decellularization: Biomedical engineering process that isolates a tissue s ECM from its inhabiting cells, leaving an ECM scaffold of the original tissue. Creates a natural biomaterial to act as a scaffold for cell growth, differentiation and tissue development. Can be recellularized with a patient s own cells for tissue regeneration to eliminate adverse immune response and rejection of donor tissue allografts. Benefits of Deceullarized Stem Cell Matrix (DSCM) DSCM offers an effective biological scaffold for controlling stem cell fate and function during tissue organization. Stem cells interact with and respond to signals and cues emanating from their ECM. Lattice Biologics recognizes that the ability to channel the regenerative potential of stem cells through decellularized ECM-based scaffolds is the future of tissue-regenerative medicine Lattice Biologics Inc. All Rights Reserved.
4 SHORTCOMINGS IN THE REGENERATIVE MEDICINE MARKET The major limitation of existing stem cell therapies is low adhesion and engraftment to sites of injury. Current donor tissue (allograft) products for bone, skin, and cartilage regeneration rely on undirected ECM scaffolds. They lack the ability to promote effective regeneration and often do not take or are rejected by the patient s immune system. CURRENT UNDIRECTED ALLOGRAFT PRODUCTS ON THE MARKET Do Not Adequately Harness Healing Potential Undirected acellular scaffolds are only a temporary void filler for tissue defects. They DO NOT: Engage cells in healing the wound site. Direct cells to regenerate intelligently as a specific tissue type (such as bone vs. skin). Take or heal wounds properly most of the time. Limited by the Quality of Patients own Stem Cells Stem cells are critical to tissue regeneration and wound healing. Over time, senescence (biological aging) erodes stem cells reparative qualities by reducing the natural homing abilities that enable them to migrate to wound sites, adhere, engraft (establish residence), and begin healing. This renders traditional allograft products ineffective for many Lattice Biologics Inc. All Rights Reserved.
5 SOLUTION: NEXT GENERATION ECM ALLOGRAFT TECHNOLOGY Lattice Biologics Modified Extracellular Matrix is Directed Scaffold Technology derived from native ECM secreted by human Mesenchymal Stem Cells (hmsc) and enhanced for optimal regeneration, differentiation, homing, and engraftment. This dramatically improves healing capacity and reduces surgical recovery times. Human-sourced (as opposed to porcine) ECM is infused into allograft materials to synergize their healing potential. LATTICE BIOLOGICS ECM-BASED TECHNOLOGY Differentiation HMSCs possess the powerful potential to differentiate into any type of tissue. Undirected allograft products do not harness this potential. Lattice strategically applies modifiers of MSC gene expression to ECM to create directed scaffolds that direct hmscs to differentiate and regenerate as the intended bone, skin, or cartilage cells. Optimized growth conditions to promote propagation and intentional differentiation. Homing and Engraftment Decellularized cement provides a microenvironment that is engineered to enhance the ability of stem cells to adhere (engraft) and thrive. Lattice s ECM technology serves as a reservoir of proteins and growth factors that provide targeted tissue engineering treatment through the use of signaling markers that attract hmscs to the site of injury (homing) Lattice Biologics Inc. All Rights Reserved.
6 HOW OUR ECM TECHNOLOGY IMPROVES ALLOGRAFTS SHORTCOMINGS OF THE MARKET S CURRENT UNDIRECTED SCAFFOLD ALLOGRAFT PRODUCTS Inadequate Healing and Patient Outcomes These products serve only as temporary void fillers for tissue and do not actively promote healing or specific cellular regeneration (such as: bone vs. skin) at the wound/surgical site. Because these products do not actively promote regeneration, they depend solely on the quality of the Patients own stem cells for healing, which is often ineffective. BENEFITS OF LATTICE BIOLOGICS NEXT GENERATION ECM-BASED ALLOGRAFTS Dramatically Improved Healing and Reduced Recovery Times Lattice s technology is derived from native ECM secreted by human Mesenchymal Stem Cells (hmsc) and allows our allograft products to: strategically differentiate as bone, skin, or cartilage cells actively promote patient healing and specific cellular regeneration Lattice s decellularized ECM provides a microenvironment engineered to promote the ability of patients stem cells to adhere to the allograft and thrive. Through specific proteins and growth factors, we utilize signaling markers that attract patients stem cells to the injury site to promote healing Lattice Biologics Inc. All Rights Reserved.
Regenerative Medicine and Stem Cell Therapies
Regenerative Medicine and Stem Cell Therapies Regenerative Medicine Major component of successful regenerated / tissue engineered organs Scaffolds A critical element is the binding of the repopulating
More informationFOR IMMEDIATE RELEASE
FOR IMMEDIATE RELEASE Media Contact: Melanie Battista, Public Relations (TSX-V: LBL) (OTCBB: BLVKF) 16701 N 90th Street, Suite#101 Scottsdale, AZ 85260 480-563-0800 Office News@LatticeBiologics.com www.latticebiologics.com
More informationStem Cell Research From Bench to Bedside
Stem Cell Research From Bench to Bedside Stem Cell Dialogues Jan A. Nolta, Ph.D. Professor, Internal Medicine Director, UC Davis Institute for Regenerative Cures October 26, 2010 Stem Cells at UC Davis
More informationFDA Regulatory, Compliance and Policy Developments: 361 HCT/Ps
FDA Regulatory, Compliance and Policy Developments: 361 HCT/Ps September 27, 2018 Presentation by: Elaine H. Tseng Partner FDA and Life Sciences Group King & Spalding Discussion with: Thomas Poché Vice
More informationThe niche/microenvironment shapes the fate of researchers and stem cells
The niche/microenvironment shapes the fate of researchers and stem cells Beate Heissig, MD Division of Stem Cell Dynamics Center of Stem Cell Biology and Regenerative Medicine The Institute of Medical
More informationAt the conclusion of this lesson you should be able to:
Learning Objectives At the conclusion of this lesson you should be able to: Understand the key terms and definitions regarding stem cells Differentiate between the adult and embryonic stem cells Differentiate
More informationThe NYSCF Research Institute
Regenerative Medicine Research Update Susan L. Solomon The NYSCF Research Institute New York Pharma Forum February 25, 2016 Regenerative Medicine Research Regenerative medicine uses laboratory grown human
More informationBackground. Background. Background. Background. Background 3/4/2013
3/4/213 Human Very Small Embryonic-like Stem Cells (s) Capacity to Regenerate Bone Tissue: A Potential Cell-based Therapy for Autogenous Bone Grafting Aaron M. Havens, DMD Need to discover an improved
More informationA review of Dr. Dinakar Golla s clinical research with AdMatrix surgical grafts for soft tissue repair
TEAMeffort: Using aggressive surgical techniques in combination with AdMatrix (Lattice Biologics acellular dermal scaffold product) to heal difficult and persistent wounds A review of Dr. Dinakar Golla
More informationInvestor Presentation GUY COOK CEO
Investor Presentation GUY COOK CEO FORWARD LOOKING STATEMENTS This presentation contains certain disclosures that may be deemed forward-looking statements within the meaning of the Private Securities Litigation
More informationStem cells and tissue engineering
Stem cells and tissue engineering S. Swaminathan Director Centre for Nanotechnology & Advanced Biomaterials School of Chemical & Biotechnology SASTRA University Thanjavur 613 401 Tamil Nadu Joint Initiative
More informationAdipose rabbit mesenchymal stem cells for the treatment of the chronic scar tissue of the vocal cords
Adipose rabbit mesenchymal stem cells for the treatment of the chronic scar tissue of the vocal cords Dr. Vasiliki E Kalodimou, Head of Flow Cytometry-Research and Regenerative Medicine Department, IASO-Maternity
More informationDes cellules-souches dans le poumon : pourquoi faire?
Des cellules-souches dans le poumon : pourquoi faire? Karl-Heinz Krause Dept. of Pathology and Immunology, Medical Faculty Dept. of Genetic and Laboratory Medicine, University Hospitals Geneva, Switzerland
More informationAnika Therapeutics, Inc.
Anika Therapeutics, Inc. Jefferies Global Healthcare Conference June 4, 2015 Safe Harbor Statement The statements made in this presentation that are not statements of historical fact are forward looking
More informationUNIT CELL PROCESSES UNDERLYING TISSUE ENGINEERING AND REGENERATIVE MEDICINE
Massachusetts Institute of Technology Harvard Medical School Brigham and Women s Hospital VA Boston Healthcare System 2.79J/3.96J/20.441/HST522J UNIT CELL PROCESSES UNDERLYING TISSUE ENGINEERING AND REGENERATIVE
More informationDeveloping Targeted Stem Cell Therapeutics for Cancer. Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013
Developing Targeted Stem Cell Therapeutics for Cancer Shawn Hingtgen, Ph.D. Assistant Professor UNC Eshelman School of Pharmacy May 22 nd, 2013 The Challenge of Drug Delivery for Brain Cancer Stem Cells
More informationInvestor Presentation GUY COOK CEO
Investor Presentation GUY COOK CEO FORWARD LOOKING STATEMENTS This presentation contains certain disclosures that may be deemed forward-looking statements within the meaning of the Private Securities Litigation
More informationLecture Outline. History. Purpose? Func:on of Bioscaffolds. Extracellular Matrix (ECM) 12/08/15
Associate Professor Rod Dilley Dr Rob Marano Ear Sciences Centre School of Surgery Harry Perkins Research Building 4 th Floor Lecture Outline History Purpose Functions Properties Approaches to bioscaffold
More informationThe Role of Adult Stem Cells in Personalized and Regenerative Medicine
The Role of Adult Stem Cells in Personalized and Regenerative Medicine Christopher J. Neill, Director of Corporate Operations American CryoStem Corporation Objective To illustrate the potential benefits
More informationWhat is the future of ACL reconstruction?
What is the future of ACL reconstruction? Charles J. Gatt, Jr., MD Chair, Department of Orthopaedic Surgery Rutgers Robert Wood Johnson Medical School New Brunswick, NJ Clinical question Do patients with
More informationFuture of Stem Cell Engineering. Jaeseung Jeong, Ph.D Department of Bio and Brain Engineering KAIST
Future of Stem Cell Engineering i Jaeseung Jeong, Ph.D Department of Bio and Brain Engineering KAIST Keywords of Stem Cell Engineering g Embryo and Fetus (Foetus) Adult stem cells and embryonic stem cells
More information20 years. Healed! What did he say? Just got home from the doctor. How s Dad?
2 0 1 2 A N N U A L R E P O R T How s Dad? Just got home from the doctor. What did he say? Healed! 20 years of stem cell research, development, and global leadership distilled into the only word that matters
More informationChondrogenic Differentiation of hmscs on PCL Nanofibers
Chondrogenic Differentiation of hmscs on PCL Nanofibers Winnie Kuo University of California, Berkeley Final Presentation for NSF-REU at UIC August 3, 2006 Advisors: Prof. Cho, Prof. Megaridis, Joel Wise
More informationCharacterisation of the osteogenic differentiation of human mesenchymal stem cells using Raman spectroscopy Lindsay L. McManus
Characterisation of the osteogenic differentiation of human mesenchymal stem cells using Raman spectroscopy Lindsay L. McManus IOM3 Young Persons World Lecture Competition São Paulo, Brazil 29 th September
More informationINUED DISCONTINUED DISCONTINUED DISCON MAKING THE IMPOSSIBLE POSSIBLE CENTER FOR REGENERATIVE MEDICINE
INUED DISCONTINUED DISCONTINUED DISCON MAKING THE IMPOSSIBLE POSSIBLE CENTER FOR > SOLUTIONS AND HOPE Millions of people worldwide suffer from deadly diseases, chronic conditions and congenital disorders
More informationGrowth factor delivery
Growth factor delivery S. Swaminathan Director Centre for Nanotechnology & Advanced Biomaterials School of Chemical & Biotechnology SASTRA University Thanjavur 613 401 Tamil Nadu Joint Initiative of IITs
More informationTISSUE ENGINEERING AND REGENERATION: TECHNOLOGIES AND GLOBAL MARKETS
TISSUE ENGINEERING AND REGENERATION: TECHNOLOGIES AND GLOBAL MARKETS HLC101B August 2014 Yojana Jeevane Project Analyst ISBN: 1-56965-894-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA
More informationRegulation of advanced blood cell therapies
Regulation of advanced blood cell therapies www.pei.de Clinical trials using cell-based products Substantially manipulated cells and cells for non-homologous use Quality, safety and non-clinical aspects
More informationAlliqua BioMedical Investor Presentation August 2017 NASDAQ: ALQA
Alliqua BioMedical Investor Presentation August 2017 NASDAQ: ALQA Forward Looking Statements Safe Harbor Statement This presentation contains forward-looking statements. Forward-looking statements are
More informationRegulatory science insights into cellular products and practical microscale technologies for their assessment
Regulatory science insights into cellular products and practical microscale technologies for their assessment Kyung Sung Johnny Lam November 9, 2018 Cellular and Tissue Therapies Branch Division of Cellular
More informationPromises and Challenges
Vladimir Mironov & Richard Visconti Regenerative Medicine: Promises and Challenges What is Regenerative Medicine? Regeneration is a well known biological term and phenomenon. According to the popular Webster
More information3/20/2017. R 3 Repair Paradigm REGENERATIVE MEDICINE GLOSSARY OF STEM CELL PLATFORMS. Limitations of Embryonic Stem Cells
R 3 Repair Paradigm CENTER FOR REGENERATIVE MEDICINE Regenerative Medicine Regulatory And Practice Management Focus Replacement ACL/UCL Reconstruction Regeneration Next generation therapy Repair Rejuvenation
More informationCellular repair of damaged organs. Repopulating scaffoldings in kidney and liver
Cellular repair of damaged organs Repopulating scaffoldings in kidney and liver Mireia Caralt, MD PhD Servei Cirurgia HBP i Trasplantaments March 29, 2017 Introduction Strategies to increase the number
More informationEMA s role & responsibility for the development of modern/advanced therapies
EMA s role & responsibility for the development of modern/advanced therapies Agenda Current regulatory picture Overall Regulatory framework New Committee at EMA Current Activities & Challenges Egbert Flory
More informationThe Biomechanics of ProLayer Acellular Dermal Matrix: suture retention strength
The Biomechanics of ProLayer Acellular Dermal Matrix: suture retention strength Reginald Stilwell, B.S., C.T.B.S., Ryan Delaney, M.S. ProLayer, Centennial, CO Basic science volume 2 ProLayer Acellular
More informationRegenerative Medicine. Speaker Disclosures. What is regenerative medicine? 6/22/2016
Regenerative Medicine Halland Chen, MD Speaker Disclosures I disclose that I am not a consultant or have any financial interests. 2 What is regenerative medicine? Regeneration of human cells, tissues,
More informationBiomaterials in regenerative medicine. Synthetic materials. Dr. Uwe Freudenberg
Biomaterials in regenerative medicine Synthetic materials Dr. Uwe Freudenberg freudenberg@ipfdd.de . most of the current medical devices do not cure diseases but only treat symptoms. What is missing there?
More informationErectile and voiding dysfunction: will stem cells solve it all?
Erectile and voiding dysfunction: will stem cells solve it all? Maarten Albersen MD PhD Dept. of Development and Regeneration Leuven University, Belgium Disclosures No conflicts of interest. ED stem cell
More informationNanosystems in regenerative medicine. Jöns Hilborn Materials Chemistry The Ångström Laboratory Uppsala University Sweden
Nanosystems in regenerative medicine Jöns Hilborn Materials Chemistry The Ångström Laboratory Uppsala University Sweden Outline Motivation for tissue regeneration Cell based approaches Material based
More informationAssuring Multipotency of human Mesenchymal Stem Cells (hmsc)
Assuring Multipotency of human Mesenchymal Stem Cells (hmsc) Introduction Over the past decade, stem cell research has provided new avenues for deeper investigation into tissue repair and aging processes,
More informationOutcomes in Mesenchymal Stem Cell Manufacturing. Athena Russell, MT(AAB) Human Cellular Therapy Laboratory Mayo Clinic Jacksonville, FL
Outcomes in Mesenchymal Stem Cell Manufacturing Athena Russell, MT(AAB) Human Cellular Therapy Laboratory Mayo Clinic Jacksonville, FL Background HCTL established in 1992 to support BMT programs of Mayo
More information1) Determining the best cell sources and scaffold materials for TEHV development.
Broadly speaking, my primary research interests focus on the development and application of methodologies that can be employed in the basic understanding and optimization of tissue engineered heart valves
More informationBEH.462/3.962J Molecular Principles of Biomaterials Spring 2003
Lecture 6: Biodegradable Polymers for Tissue Engineering Last time: Today: enzymatic degradation of solid polymers Engineering biological recognition of polymers Designing polymers for tissue engineering
More informationTissue Engineering and Regenerative Medicine
Tissue Engineering and Regenerative Medicine NIH Center for Engineering Complex Tissues (CECT) June 8, 2018 Bhushan Mahadik, Ph.D. Assistant Director, CECT University of Maryland Regenerative Medicine
More informationTHE SCIENCE OF PLATELET RICH PLASMA
THE SCIENCE OF PLATELET RICH PLASMA Cheri A. Ong, MD FACS ONG INSTITUTE FOR PLASTIC SURGERY & HEALTH WHAT IS PRP BLOOD PLASMA 55% of the body s today body volume 45% blood cells:- Red blood cells, White
More informationEngineering, Columbia University, New York, NY, USA; 3 Departments of Biomedical Engineering and Medicine, Columbia University, New York, NY USA
Creation of Live Lung Slices and Analysis of Cell-Matrix Interactions for Regionalized Human Lung Regeneration Sneha Subramaniam 1 *, John O'Neill 2, Gordana Vunjak-Novakovic 3 1 Columbia College, Columbia
More informationMedical Topics: Gene Therapy. E. Anne Jackson, FSA MAAA July 30, 2018
Medical Topics: Gene Therapy E. Anne Jackson, FSA MAAA July 30, 2018 Agenda Terminology Crash course in the science Existing FDA-approved gene therapies Underwriting implications 2 Terms related to high
More informationStem cells in Development
ANAT 2341 Embryology Lab 10 8 Oct 2009 Therapeutic Use of Stem Cells Practical Hurdles & Ethical Issues Stem cells in Development Blastocyst Cord blood Antonio Lee PhD Neuromuscular & Regenerative Medicine
More informationStem cells in Development
ANAT 2341 Embryology Lab 10 8 Oct 2009 Therapeutic Use of Stem Cells Practical Hurdles & Ethical Issues Stem cells in Development Blastocyst Cord blood Antonio Lee PhD Neuromuscular & Regenerative Medicine
More informationAnika Therapeutics, Inc.
Anika Therapeutics, Inc. Canaccord Genuity 34th Annual Growth Conference August 14 th, 2014 Safe Harbor Statement The statements made in this presentation, which are not statements of historical fact,
More informationAndrew Finnerty General Manager - CCMI
Andrew Finnerty General Manager - CCMI Manufacturing Human Mesenchymal Stem Cells for Clinical Trials Quality Considerations Biopharma and Pharma RQA Regional Forum Bioclin Laboratories, Athlone 13 May
More informationWhole Organ Bioengineering Science & Sensibility. Doris A. Taylor, PhD, FAHA, FACC Director, Regenerative Medicine Research Texas Heart Institute
Whole Organ Bioengineering Science & Sensibility Doris A. Taylor, PhD, FAHA, FACC Director, Regenerative Medicine Research Texas Heart Institute Disclosure Founder/Consultant/shareholder Miromatrix Medical
More informationTestimony of the Biotechnology Industry Organization (BIO) Before the Texas House of Representatives State Affairs Committee
Testimony of the Biotechnology Industry Organization (BIO) Before the Texas House of Representatives State Affairs Committee Regarding House Bill 1929 The Use of Human Cells and Tissue April 11, 2005 Thank
More informationFORWARD-LOOKING STATEMENTS
FORWARD-LOOKING STATEMENTS The statements made by Kensey Nash and its representatives in this presentation will include certain forward-looking statements, including financial forecasts, that are based
More informationStem Cells and Regenerative Medicine
Q 0 Stem Cells and Regenerative Medicine Technologies and capabilities to add value to your company Differentiation HA-PPS for cartilage Parallel culture optimisation Stem Cell Therapies Fetal EPCs and
More informationStem Cells Canadian Perspective
Stem Cells Canadian Perspective John Laffey Critical Illness and Injury Research Centre, Keenan Research Centre, St Michael s Hospital. Departments of Anesthesia, Physiology and Interdepartmental Division
More informationSpecial Issue. Mesoblast Limited
Overview is an Australian biotechnology company committed to the commercialization of novel treatments for orthopedic conditions by using its unique adult stem cell technology for the regeneration and
More informationStem Cell Principle -
Effective Date: 31.10.2017 Doc ID: 20290214 Version: 1.0 Status: Approved Planned Effective Date: 31-Oct-2017 00:00 CET (Server Date) Stem Cell Principle - Rationale Research on human stem cells and their
More informationWelcome all. Principles of Tissue Engineering AMME4971 & AMME5971. Convenor: Professor Hala Zreiqat
Welcome all Principles of Tissue Engineering AMME4971 & AMME5971 Convenor: Professor Hala Zreiqat Email: hala.zreiqat@sydney.edu.au Office S511 AMME JO7 Tissue Engineering and Biomaterials Research Unit
More informationFuture implications of regenerative medicine on assisted reproductive technology. Regenerative medicine. History of Regenerative medicine
Gyndolomiti: 2nd Congress on Gynaecology and Obstetrics February 1 6, 2015 St. Kassian / South Tyrol Regenerative medicine Future implications of regenerative medicine on assisted reproductive technology
More informationLooking Ahead: The Bio-Artificial Kidney
Looking Ahead: The Bio-Artificial Kidney Teja Guda, PhD Assistant Professor, Department of Biomedical Engineering Assistant Director, Center for Innovation Technology and Entrepreneurship University of
More informationYOUR OWN LIFE
YOUR OWN LIFE Stromal Tissue (ST), a Regenerative Source There is a worldwide consensus that the isolation and collection of regenerative Mesenchymal Stem Cells (MSC s) from differentiated body tissues
More informationSabrina Jedlicka. Interactions of Neurons and Materials
Sabrina Jedlicka Interactions of Neurons and Materials Developmental Cell Biology Some Perspective Stem cells: Undifferentiated cells that are capable of proliferation, self-maintenance and differentiation
More informationRegulatory requirements for cell based medicinal products
Regulatory requirements for cell based medicinal products 資料 3-2 Committee 25 August 2010 Dr. Bettina Klug, MSc Paul-Ehrlich-Institut, Langen klube@pei.de Paul-Ehrlich-Institut Federal Institute for Vaccines
More informationCourse Handbook MSc in Bioengineering Tissue Engineering Specialisation
Course Handbook 2013-2014 MSc in Bioengineering Tissue Engineering Specialisation 1 Course Objectives & Learning Outcomes This programme aims to give a sound and broad basis in tissue engineering. In particular,
More informationISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development
ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development University of Wisconsin-Madison, Production Assistance for Cellular Therapies (PACT) Over the
More informationBNG 331 Cell-Tissue Material Interactions. Wound Healing I
BNG 331 Cell-Tissue Material Interactions Wound Healing I Course update LBL 4 Friday; paper posted Need a volunteer to switch groups! Much better job on LBL 3 figure summaries BNG spring seminar 3 this
More informationPresent and future of regenerative medicine. Liver Transplantation
Present and future of regenerative medicine Liver Transplantation Mireia Caralt, MD PhD Servei Cirurgia HBP i Trasplantaments March 19, 2015 Introduction Strategies to increase the number of organs EXPAND
More informationTissue Engineering: The art of growing body parts. Robby Bowles, Ph.D Cornell University
Tissue Engineering: The art of growing body parts Robby Bowles, Ph.D Cornell University What is Tissue Engineering? What is Tissue Engineering? TE is an interdisciplinary field that applies the principles
More informationhpsc Growth Medium DXF Dr. Lorna Whyte
hpsc Growth Medium DXF Dr. Lorna Whyte 27.06.2014 Training from Heidelberg Overview Background: Stem Cells Introduction: Human Pluripotent Stem Cells (hpsc) vs. Adult Stem Cells Promise of PSC Research
More informationLyset BOOST YOUR CELL CULTURE TODAY FOR THE EXPERIMENTS OF TOMORROW
Lyset BOOST YOUR CELL CULTURE TODAY FOR THE EXPERIMENTS OF TOMORROW Lyset, the human platelet derived supplement for cell culture Among the different alternatives to animal serum, platelet derived preparations
More informationCHALLENGES OF 3D BIOPRINTING IN CLINICAL PRACTICE
CENTRE DE THÉRAPIE TISSULAIRE & CELLULAIRE CHALLENGES OF 3D BIOPRINTING IN CLINICAL PRACTICE Pr. D. Dufrane MD, PhD 3D-BIOPRINTING: MYTH OR REALITY? 2 REGENERATIVE MEDICINE FOR ORGAN AND TISSUE A LARGE
More informationRegeneration of spinal cord injury (SCI) : What we know so far. By: Kendra Michaud
Regeneration of spinal cord injury (SCI) : What we know so far By: Kendra Michaud INTRODUCTION BACKGROUND/IMPACT Neerumalla, Dr. Ravali. Spinal Cord Injury - Causes, Symptoms, Diagnosis, Treatment & Prevention.
More informationCHAPTER 8. orthopaedic and bone tissue engineering applications.
CHAPTER 8 Study the synergistic effect of collagen type I, hyaluronic acid and chitosan on adhesion, proliferation and osteoblast differentiation of bone marrow derived human mesenchymal stem cells. 8.1
More informationKieran McGourty, PhD. Short BIO. Long BIO
Kieran McGourty, PhD Lecturer in Biochemistry and Cell Biology, Department of Chemical Sciences University of Limerick, Ireland Short BIO Kieran did his PhD and his Post-Doctoral scientific training in
More informationIntroduction to Cell/ Biomaterial Engineering
Introduction to Cell/ Biomaterial Engineering Module 3, Lecture 1! 20.109 Spring 2011! Topics for Lecture 1 Introduction to tissue engineering! motivation! basic principles + examples! Introduction to
More informationUnderstanding brain diseases from stem cells to clinical trials
Understanding brain diseases from stem cells to clinical trials Alan Mackay Sim Griffith Institute for Drug Discovery Griffith University Brisbane, QLD Making ES cells Fertilise an egg Put in a dish Embryonic
More informationTendon/Ligament Repair
Tendon/Ligament Repair Team Collagen Constructs Mario Rossi, Anne Tucker, Brian Ziola Faculty Advisors: Dr. Yawen Li, Dr. Therese Bou-Akl Technical Advisors: Dr. Tristan Maerz, Meagan Salisbury Problem
More informationMonteiro, G., Sundararaghavan, H. Fernandes, A. and Shreiber, D. Rutgers, the State University of New Jersey, New Brunswick, NJ, USA
Monteiro, G., Sundararaghavan, H. Fernandes, A. and Shreiber, D. Rutgers, the State University of New Jersey, New Brunswick, NJ, USA Introduction: Cell migration is a ubiquitous process that is of fundamental
More informationFundamental properties of Stem Cells
Stem cells Learning Goals: Define what a stem cell is and describe its general properties, using hematopoietic stem cells as an example. Describe to a non-scientist the current progress of human stem cell
More informationStem Cells: Introduction and Prospects in Regenerative Medicine.
Stem Cells: Introduction and Prospects in Regenerative Medicine www.gothamgazette.com/.../stemcell/stem_cell.jpg Ode to a Stem Cell, Part II by VCW There once was stem cell stuck in the hood Dividing endlessly,
More information??? Bioparc Bordeaux Métropole F Pessac CNRS. Poietis
??? Bioparc Bordeaux Métropole F-33600 Pessac www.poietis.com 1 / 23 Company Profile Business: Provide patients and clinicians with Regenerative Medicine Therapies based on Laser-Assisted Bioprinting Overview
More informationStem Cell Research 101
Stem Cell Research : A promising type of bioscience research The Stem Cell debate and the impact of the induced pluripotent stem cell procedure Why Is Vocabulary Important? Key terms frame the debate Mature
More informationCell membrane repair in acute lung injury: from bench to bedside. Disclosure. Cell membrane repair is an elemental physiological process
Cell membrane repair in acute lung injury: from bench to bedside Disclosure Jianjie Ma, Ph.D. Karl P. Klassen Chair of Thoracic Surgery Department of Surgery Davis Heart and Lung Research Institute The
More informationCells Culture Techniques Marta Czernik
Cells Culture Techniques 13.03.2018 Marta Czernik Why we need the cell/tissue culture Research To overcome problems in studying cellular behaviour such as: - confounding effects of the surrounding tissues
More informationAthought-provoking study, recently published in Nature Reviews Genetics,1
Australia Athought-provoking study, recently published in Nature Reviews Genetics,1 considered the consequences of an increased exposure to micronutrients. A tricky question, given the widespread, sometimes
More informationSTEM CELLS BONE FRACTURE
BIOLOGY UNIT 2 MRS. CATHERINE JACKSON STEM CELLS BONE FRACTURE By AYESHA SYED 10C 2 Stem Cell (Introduction) Stem cells are undifferentiated cells that have not yet become a specialised cell, with a specific
More informationUSAMRMC STRATEGIC COMMUNICATION PLAN ARMED FORCES INSTITUTE OF REGENERATIVE MEDICINE (AFIRM)
ARMED FORCES INSTITUTE OF REGENERATIVE MEDICINE (AFIRM) MISSION The Armed Forces Institute of Regenerative Medicine is dedicated to repairing battlefield injuries through the use of regenerative medicine
More informationEuropean Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York
European Regenerative Medicine Firms & Their Strategic Approaches Michael Morrison University of York OVERVIEW Creating the European RM Universe of firms Characterizing the European RM Universe Strategic
More informationLongevity Leaders Conference. February 4, 2019
Longevity Leaders Conference February 4, 2019 Forward Looking Statements The matters discussed in this presentation include forward looking statements which are subject to various risks, uncertainties,
More informationCross-Linker Modulation to Maintain Phenotype of RGD-Alginate-Embedded Mesenchymal Stem Cells
Cross-Linker Modulation to Maintain Phenotype of RGD-Alginate-Embedded Mesenchymal Stem Cells Ashley B. Allen, Hazel Y. Stevens, Robert E. Guldberg. Georgia Institute of Technology, Atlanta, GA, USA. Disclosures:
More informationUnited Kingdom Tissue Engineered - Skin Substitutes Market Outlook to 2020
United Kingdom Tissue Engineered - Skin Substitutes Market Outlook to Reference Code: GDMECC0860DB Publication Date: October 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...
More informationStem Cell Therapy for Wound Healing in Diabetic Limb
Stem Cell Therapy for Wound Healing in Diabetic Limb Tanom Bunaprasert M.D. EC-ATMPs ( EC- Advanced Therapy Medicinal Products) Chulalongkorn Hospital Authority of Laws Public Health Safety act (
More informationDR. ALLEVABLE S UNBELIEVABLE LAB
Grade Level 3-6 Your students will learn: What Regenerative Medicine and Tissue Engineering are. Examples of the kinds of injuries Regenerative Medicine can help heal. How stem cells are used in Regenerative
More informationAdult Stem Cells for Chronic Pain. Dr. John Hughes, DO January 24 th, 2018
Adult Stem Cells for Chronic Pain Dr. John Hughes, DO January 24 th, 2018 Dr. John Hughes, DO Doctor of Osteopathy From Georgia Arizona College of Osteopathic Medicine - 2007 Aspen Integrative Medicine
More informationGene Expression in Stem Cells Featured scientist: Adam Heck from Colorado State University
Gene Expression in Stem Cells Featured scientist: Adam Heck from Colorado State University Research Background: Every cell in your body contains the same DNA. How is it that genetically identical skin,
More informationDiscover TruPRP. PRP the way you want it.
Discover TruPRP PRP the way you want it. Discover TruPRP Discover the quality of Magellan TruPRP. The Magellan technology provides an automated dual spin processing system that can deliver (PRP) Platelet
More informationStem Cells & Neurological Disorders. Said Ismail Faculty of Medicine University of Jordan
Stem Cells & Neurological Disorders Said Ismail Faculty of Medicine University of Jordan Outline: - Introduction - Types & Potency of Stem Cells - Embryonic Stem Cells - Adult Stem Cells - ipscs -Tissue
More informationARTHREX ACP. Features and Benefits: Introduction
ARTHREX ACP Introduction Autologous blood products have created a growing interest for use in a number of orthopaedic therapies. The healing effects of plasma are supported by growth factors released by
More informationANAT 2341 Embryology Lecture 18 Stem Cells
ANAT 2341 Embryology Lecture 18 Stem Cells 29 September 2010 Dr Antonio Lee Neuromuscular & Regenera
More information